For BCR::ABL1-positive cases, particularly those expressing the p190 isoform, MRD tracking using qPCR is routinely applied in CML and was adapted here as a surrogate marker in this high-risk AML setting [18]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.